Insulin-like Peptide-6 Levels in Non-obstructive Azoospermia

Area of Science:

• Reproductive Endocrinology
• Male Infertility Research
• Biomarker Discovery

Background:

• Non-obstructive azoospermia (NOA) is a significant cause of male infertility.
• Insulin-like peptide-6 (INSL-6) is a peptide hormone with potential roles in reproduction.
• Understanding biomarkers for NOA is crucial for diagnosis and treatment.

Purpose of the Study:

• To compare serum and seminal insulin-like peptide-6 (INSL-6) levels in men with non-obstructive azoospermia (NOA) and normospermia.
• To investigate potential correlations between INSL-6 levels and clinical parameters in these groups.

Main Methods:

• A descriptive study involving 80 men (40 NOA, 40 normospermia).
• Serum and seminal INSL-6 levels were measured using enzyme-linked immunosorbent assay (ELISA).
• Comparisons included age, BMI, hormone profiles, testicular volumes, and INSL-6 levels.

Main Results:

• Seminal INSL-6 levels were significantly higher in the normospermia group compared to NOA.
• No significant differences in serum INSL-6 levels were found between groups.
• A significant negative association was observed between seminal INSL-6 levels and testicular volume.

Conclusions:

• Seminal INSL-6 levels are substantially higher than serum levels and are elevated in normospermic men.
• These findings suggest INSL-6 has an active role in the male reproductive system.
• Further research is needed to elucidate the precise mechanism and extent of INSL-6's reproductive function.